|

Motivational Enhancement Therapy's Impact on d COPD Outcomes in Geriatric Patient

RECRUITINGN/ASponsored by Alexandria University
Actively Recruiting
PhaseN/A
SponsorAlexandria University
Started2024-06-01
Est. completion2024-09-01
Eligibility
Age60 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06421896

Summary

Motivational Enhancement Therapy (MET) is a systematic intervention that focuses on eliciting and strengthening a person's intrinsic motivation to change. MET is rooted in motivational interviewing principles, emphasizing empathy, autonomy, and the evocation of the patient's own motivations for change. The therapy typically involves several sessions where therapists help patients identify personal goals, explore ambivalence towards change, and develop actionable plans to achieve their desired outcomes.

Eligibility

Age: 60 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* more than 60 years

Exclusion Criteria:

* more than 80 years

Conditions2

AnxietyCOPD

Browse More Trials

Anxiety trialsCOPD trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.